# Scientists Reveal How Alzheimer's Drug Lecanemab Actually Works, Opening Door to New Therapies

*2026-03-17 20:02 UTC · Science · 1 min read*

> VIB-KU Leuven researchers discovered lecanemab clears brain plaques by activating immune cells through its Fc fragment, opening the door to next-generation Alzheimer's treatments.

Researchers at the VIB-KU Leuven Center for Brain & Disease Research have uncovered the hidden mechanism behind lecanemab (Leqembi), the FDA-approved Alzheimer's drug. The study, published in Nature Neuroscience and led by Prof. Bart De Strooper, found that the drug clears toxic amyloid plaques by activating the brain's immune cells — microglia — through a specific part of the antibody called the Fc fragment.

Using hybrid mouse models containing human microglial cells, co-first authors Dr. Giulia Albertini and Magdalena Zielonka showed the Fc fragment acts as a trigger that reprograms microglia into an active plaque-clearing state. The team also identified SPP1/osteopontin as a key molecular factor driving effective amyloid removal.

The discovery is significant because it suggests future Alzheimer's therapies could potentially activate microglia directly, bypassing the need for antibodies altogether — a path that could lead to cheaper, more accessible treatments.

## Sources

- [sciencedaily.com](https://www.sciencedaily.com/releases/2026/03/260317064457.htm)
- [nature.com](https://www.nature.com/articles/s41593-025-02125-8)

---
TechTools News · https://techtools.cz/tools/news/article/864-scientists-reveal-how-alzheimer-s-drug-lecanemab-actually-works-opening-door-to
Česká verze: https://techtools.cz/tools/news/clanek/891-vedci-odhalili-jak-lek-na-alzheimerovu-chorobu-lecanemab-skutecne-funguje-a
